Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

Background: To optimise the use of available SARS-CoV-2 vaccines, some advocate delaying second vaccination for individuals infected within six months. We studied whether post-vaccination immune response is equally potent in individuals infected over six months prior to vaccination. Methods: We test...

Full description

Bibliographic Details
Main Authors: Brent Appelman, Karlijn van der Straten, A.H. Ayesha Lavell, Michiel Schinkel, Marleen A. Slim, Meliawati Poniman, Judith A. Burger, Melissa Oomen, Khadija Tejjani, Alexander P.J. Vlaar, W. Joost Wiersinga, Yvo M. Smulders, Lonneke A. van Vught, Rogier W. Sanders, Marit J. van Gils, Marije K. Bomers, Jonne J. Sikkens
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EBioMedicine
Subjects:
Vaccine
BNT162b2
SARS-CoV-2
COVID-19
Humoral immune response
Neutralisation
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003820

Similar Items

Similar Items